Infusion Therapy Market Size, Share & COVID19 Impact Analysis | United States | 2023-2029 | MedSuite | Includes: Infusion Pumps, Intravenous Sets, Needless Connectors, Stopcocks, Intravenous Filters & Blood Transfusion Devices

  • Year: 2023
  • Scope: 10 Years
  • Region: United States
  • Pages: 395
  • Published Date: 05/04/23
  • Type: MedSuite

Product Description

The Infusion Therapy Device Market in the United States had a valuation of $3.0 billion in 2022. With a projected compound annual growth rate (CAGR) of 2.5%, it is estimated to surpass $3.6 billion by the end of the forecast period.

Throughout this medical market research, we analyzed over 40 Infusion Therapy companies across the United States and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

The full report suite on the U.S. Market for Infusion Therapy Devices includes extensive analysis on the following segments: Infusion Pump Market, Intravenous Set Market, Needleless Connector Market, Stopcock Market, Intravenous Filter Market, and the Blood Transfusion Market.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Market Forecasts Until 2029, and Historical Data to 2019
  • Market Drivers & Limiters for Each Infusion Therapy Device market
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact on the Infusion Therapy Market in the US
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT Analysis for all Leading Competitors

Infusion Therapy Market Insights

The infusion therapy device market, being mature and stable, is expected to witness limited growth in unit sales. Infusion pumps and intravenous (IV) sets, which are the two largest segments of the market, have already reached saturation points in terms of installed base and unit sales. The established nature of infusion therapy restricts any significant expansion possibilities. Although premium-priced products with advanced features are available in the market, they have had limited success in driving market growth, as there is little evidence that these features and accessories improve clinical outcomes with routine use. Therefore, it is anticipated that the market growth will be constrained in terms of both unit sales and average selling prices.

US Infusion Therapy Market Size By Segment, 2013-2029

As healthcare costs continue to rise, the one area of the infusion therapy device market that is witnessing substantial growth is the outpatient settings market. Patients are now receiving treatments in places like homecare, specialty clinics, and ambulatory surgical centers, resulting in a higher cost per device. Due to the limited purchasing power of these alternate care sites, infusion therapy products become pricier.

U.S. Infusion Therapy Market Share Insights

US Infusion Therapy Market Leading Competitors

The presence of a few dominant players in the infusion therapy device market is likely to result in sustained high prices, driving growth throughout the forecast period. With a limited number of major competitors producing products across multiple segments that are intended to be used together, healthcare providers often prefer to purchase from a single manufacturer. To address this trend, many companies are expanding their product offerings, leading to increased competition and further market growth in the future.

Becton Dickinson emerged as the market leader in the U.S. infusion therapy device and consumables market in 2022. Its acquisition of CareFusion in 2015 served as a stepping stone to enter the market, and the company has since then strengthened its position by gradually expanding its market share in intravenous (IV) devices. Becton Dickinson is present in almost every major market segment and dominates in the top three segments, namely infusion pumps, IV sets, and needleless connectors.

ICU Medical secured the second position in the U.S. infusion therapy device market, with significant market shares in infusion pump, IV set, and needleless connector markets. Moreover, the company was the top player in the stopcock market in the United States. In 2022, ICU Medical made a significant acquisition by taking over Smiths Medical. With the anticipated product launches in the infusion therapy device market during the forecast period, ICU Medical is expected to witness growth in its market share.

Baxter held the third position in the U.S. infusion therapy device and consumables market in 2022. Although the company does not lead in any of the major segments such as infusion pumps, IV sets, needleless connectors, stopcocks, and blood transfusion sets, it offers a comprehensive range of products in all these segments. Baxter has established itself as a significant player in the market by providing high-quality products and leveraging its vast distribution network to reach a broad customer base.

Detailed Market Segmentation

  • Infusion Pumps MarketThe market is broken down into segments accordingly:
    • Large Volume Pump – Care Setting, Modularity, and MRI Compatibility.
    • Syringe Pump – Care Setting and Modularity
    • Patient-Controlled Analgesia Pump – Care Setting
    • Electronic Ambulatory Pump – Care Setting
    • Disposal Ambulatory Pump – Device Type and Care Setting
  • Intravenous Sets MarketThe market is broken down into segments accordingly:
    • Pump Set – Device Type, By Light Protection, By Patient Age, Care Setting
    • Gravity Set – by Application and Care Setting
    • Secondary Set – Care Setting
    • Extension Set – By configuration, By IV Filter, By Stopcock, By Flow Control, and Care Setting
  • Needleless Connectors Market – The Market is Segmented by:
    • Valve Type
    • Device Type
    • Antimicrobial Coating
    • Care Setting
  • Stopcocks MarketThe Market is Segmented by:
    • Flow Type
    • Care Setting
  • Intravenous Filters MarketThe Market is Segmented By:
    • Care Setting
  • Blood Transfusion Sets MarketThe Market is Segmented By:
    • Device Type – Single-Chamber and Dual-Chamber
    • Care Setting

Research Scope Summary

Report AttributeDetails
RegionsNorth America (United States)
Base Year2022
Forecast2023-2029
Historical Data2019-2022
Quantitative CoverageMarket Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative CoverageCOVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data SourcesPrimary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

 

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by selecting our complimentary executive summary below.

FREE Executive Summary

Table of Contents

TABLE of CONTENTSi
List of Figuresxi
List of Chartsxxi
executive summary1
U.S. Infusion Therapy Device Market Overview1
Competitive Analysis4
Market Trends7
Market Developments8
Markets Included9
Key Report Updates14
Version History15
research methodology16
Step 1: Project Initiation & Team Selection16
Step 2: Prepare Data Systems and Perform Secondary Research19
Step 3: Preparation for Interviews & Questionnaire Design21
Step 4: Performing Primary Research22
Step 5: Research Analysis: Establishing Baseline Estimates24
Step 6: Market Forecast and Analysis25
Step 7: Identify Strategic Opportunities27
Step 8: Final Review and Market Release28
Step 9: Customer Feedback and Market Monitoring29
impact of covid-19 on THE U.S. Infusion Therapy Device Market30
2.1 Introduction30
2.2 Analysis By Market Segment32
2.2.1 Worst Case Scenario32
2.2.2 Base Case Scenario33
2.2.3 Best Case Scenario34
Disease Overview36
3.1 Disease Treatment and Diagnostic36
3.1.1 Cancer36
3.1.2 Congestive Heart Failure38
3.1.3 Crohn’s Disease39
3.1.4 Hemophilia40
3.1.5 Multiple Sclerosis40
3.2 Patient Demographics42
3.2.1 Congestive Heart Failure42
3.2.2 Crohn’s Disease43
3.2.3 Hemophilia43
3.2.4 Multiple Sclerosis44
3.2.5 Cancer45
3.2.5.1 Breast Cancer45
3.2.5.2 Colon and Rectum46
3.2.5.3 Leukemia46
3.2.5.4 Lungs and Bronchus46
3.2.5.5 Pancreas47
Product Assessment48
4.1 Introduction48
4.2 Product Portfolios49
4.2.1 Infusion Pump49
4.2.2 Intravenous Sets52
4.2.2.1 Pump Sets52
4.2.2.2 Gravity Sets52
4.2.2.3 Secondary Sets53
4.2.2.4 Extension Sets53
4.2.3 Needleless Connectors55
4.2.3.1 Split Septum and Blunt Cannula55
4.2.3.2 Mechanical Valves55
4.2.3.3 Negative Displacement Mechanical Valves55
4.2.3.4 Positive Displacement Mechanical Valves56
4.2.3.5 Neutral Displacement Mechanical Valves56
4.2.3.6 Anti-Reflux Neutral Displacement Mechanical Valves56
4.2.3.7 Antimicrobial Needleless Connectors56
4.2.4 Stopcocks58
4.2.5 Intravenous Filters60
4.2.6 Blood Transfusion Devices61
4.3 Regulatory Issues and Recalls62
4.3.1 Infusion Pump62
4.3.2 Intravenous Sets71
4.3.3 Needleless Connector75
4.3.4 Stopcocks77
4.3.5 Blood Transfusion Devices79
4.4 Clinical Trials80
4.4.1 Infusion Pump81
4.4.2 Needleless Connectors84
4.4.3 Blood Transfusion Devices85
U.S. Infusion Therapy Device Market Overview86
5.1 Introduction86
5.2 Market Overview & Trend Analysis88
5.3 Drivers and Limiters92
5.3.1 Market Drivers92
5.3.2 Market Limiters93
5.4 Competitive Market Share Analysis96
5.5 Mergers and Acquisitions103
5.6 Company Profiles105
5.6.1 Avanos Medical105
5.6.2 B. Braun106
5.6.3 Baxter107
5.6.4 Becton Dickinson108
5.6.5 Belmont Medical110
5.6.6 CODAN111
5.6.7 Fresenius112
5.6.8 GVS Group113
5.6.9 ICU Medical114
5.6.10 Vygon115
5.7 SWOT Analysis116
5.7.1 Avanos Medical117
5.7.2 B. Braun118
5.7.3 Baxter119
5.7.4 Becton Dickinson120
5.7.5 Belmont Medical121
5.7.6 CODAN122
5.7.7 Fresenius123
5.7.8 GVS Group124
5.7.9 ICU Medical125
5.7.10 Vygon126
INFUSION PUMP Market127
6.1 Introduction127
6.2 Market Overview129
6.3 Market Analysis and Forecast132
6.3.1 Large-Volume Infusion Pump Market132
6.3.1.1 Large-Volume Infusion Pump Market by Care Setting134
6.3.1.1.1 Hospital Large-Volume Infusion Pump Market136
6.3.1.1.2 Specialty Clinics Large-Volume Infusion Pump Market138
6.3.1.1.3 Ambulatory Surgical Center Large-Volume Infusion Pump Market139
6.3.1.1.4 Home Care Setting Large-Volume Infusion Pump Market140
6.3.1.2 Large-Volume Infusion Pump Market by Modularity141
6.3.1.2.1 Modular Large-Volume Infusion Pump Market143
6.3.1.2.2 Non-Modular Large-Volume Infusion Pump Market144
6.3.1.3 Large-Volume Infusion Pump Market by MRI Compatibility145
6.3.1.3.1 MRI-Compatible Large-Volume Infusion Pump Market147
6.3.1.3.2 Non-MRI-Compatible Large-Volume Infusion Pump Market148
6.3.2 Syringe Infusion Pump Market149
6.3.2.1 Syringe Infusion Pump Market by Care Setting151
6.3.2.1.1 Hospital Syringe Infusion Pump Market153
6.3.2.1.2 Specialty Clinics Syringe Infusion Pump Market154
6.3.2.1.3 Ambulatory Surgical Center Syringe Infusion Pump Market155
6.3.2.1.4 Home Care Setting Syringe Infusion Pump Market156
6.3.2.2 Syringe Infusion Pump Market by Modularity157
6.3.2.2.1 Modular Syringe Infusion Pump Market159
6.3.2.2.2 Non-Modular Syringe Infusion Pump Market160
6.3.3 Patient-Controlled Analgesia Infusion Pump Market161
6.3.3.1 Patient-Controlled Analgesia Infusion Pump Market by Care Setting163
6.3.3.1.1 Hospital Patient-Controlled Analgesia Infusion Pump Market165
6.3.3.1.2 Specialty Clinics Patient-Controlled Analgesia Infusion Pump Market166
6.3.3.1.3 Ambulatory Surgical Center Patient-Controlled Analgesia Infusion Pump Market167
6.3.3.1.4 Home Care Setting Patient-Controlled Analgesia Infusion Pump Market168
6.3.4 Electronic Ambulatory Infusion Pump Market169
6.3.4.1 Electronic Ambulatory Infusion Pump Market by Care Setting170
6.3.4.1.1 Hospital Electronic Ambulatory Infusion Pump Market172
6.3.4.1.2 Specialty Clinics Electronic Ambulatory Infusion Pump Market173
6.3.4.1.3 Ambulatory Surgical Center Electronic Ambulatory Infusion Pump Market174
6.3.4.1.4 Home Care Setting Electronic Ambulatory Infusion Pump Market175
6.3.5 Disposable Ambulatory Infusion Pump Market176
6.3.5.1 Disposable Ambulatory Infusion Pump Market by Type177
6.3.5.1.1 Disposable Ambulatory Non-Pain Infusion Pump Market178
6.3.5.1.2 Disposable Ambulatory Pain Infusion Pump Market by Type179
6.3.5.2 Disposable Ambulatory Infusion Pump Market by Care Setting183
6.3.5.2.1 Hospital Disposable Ambulatory Infusion Pump Market185
6.3.5.2.2 Specialty Clinics Disposable Ambulatory Infusion Pump Market186
6.3.5.2.3 Ambulatory Surgical Center Disposable Ambulatory Infusion Pump Market187
6.3.5.2.4 Home Care Setting Disposable Ambulatory Infusion Pump Market188
6.4 Drivers and Limiters189
6.4.1 Market Drivers189
6.4.2 Market Limiters192
6.5 Competitive Market Share Analysis195
Intravenous Set Market201
7.1 Introduction201
7.2 Market Overview202
7.2.1 Market Overview by Device Type202
7.2.2 Market Overview by Material205
7.3 Market Analysis and Forecast207
7.3.1 Intravenous Set Market by Device Type207
7.3.1.1 Pump Set Market207
7.3.1.1.1 Pump Set Market by Device Type209
7.3.1.1.2 Pump Set Market by Light Protection217
7.3.1.1.3 Pump Set Market by Patient Age220
7.3.1.1.4 Pump Set Market by Care Setting223
7.3.1.2 Gravity Set Market228
7.3.1.2.1 Gravity Set Market by Application229
7.3.1.2.2 Gravity Set Market by Care Setting248
7.3.1.3 Secondary Set Market253
7.3.1.3.1 Secondary Set Market by Care Setting254
7.3.1.4 Extension Set Market259
7.3.1.4.1 Extension Set Market by Configuration261
7.3.1.4.2 Extension Set Market by IV Filter264
7.3.1.4.3 Extension Set Market by Stopcock268
7.3.1.4.4 Extension Set Market by Flow Control271
7.3.1.4.5 Extension Set Market by Care Setting275
7.3.2 Intravenous Set Market by Material280
7.3.2.1 DEHP IV Set Market280
7.3.2.2 Non-DEHP IV Set Market281
7.4 Drivers and Limiters282
7.4.1 Market Drivers282
7.4.2 Market Limiters283
7.5 Competitive Market Share Analysis285
Needleless Connector Market289
8.1 Introduction289
8.2 Market Overview290
8.2.1 Market Overview by Valve Type290
8.2.2 Market Overview by Device Type293
8.2.3 Market Overview by Antimicrobial Coating295
8.2.4 Market Overview by Care Setting297
8.3 Market Analysis and Forecast299
8.3.1 Total Needleless Connector Market299
8.3.2 Needleless Connector Market by Valve Type300
8.3.2.1 Split Septum and Blunt Cannula Needleless Connector Market300
8.3.2.2 Mechanical Valve Needleless Connector Market by Device Type302
8.3.2.2.1 Negative Displacement Mechanical Valve Needleless Connector Market305
8.3.2.2.2 Positive Displacement Mechanical Valve Needleless Connector Market306
8.3.2.2.3 Neutral Displacement Mechanical Valve Needleless Connector Market307
8.3.2.2.4 Anti-Reflux Neutral Displacement Mechanical Valve Needleless Connector Market308
8.3.3 Needleless Connector Market by Device Type309
8.3.3.1 Standalone Needleless Connector Market310
8.3.3.2 Integrated Needleless Connector Market311
8.3.4 Needleless Connector Market by Antimicrobial Coating312
8.3.4.1 Antimicrobial Needleless Connector Market314
8.3.4.2 Conventional Needleless Connector Market315
8.3.5 Needleless Connector Market by Care Setting316
8.3.5.1 Hospital Needleless Connector Market317
8.3.5.2 Specialty Clinics Needleless Connector Market318
8.3.5.3 Ambulatory Surgical Center Needleless Connector Market319
8.3.5.4 Home Care Setting Needleless Connector Market321
8.4 Drivers and Limiters322
8.4.1 Market Drivers322
8.4.2 Market Limiters323
8.5 Competitive Market Share Analysis324
Stopcock Market328
9.1 Introduction328
9.2 Market Overview329
9.2.1 Market Overview by Flow Type329
9.2.2 Market Overview by Care Setting332
9.3 Market Analysis and Forecast334
9.3.1 Total Stopcock Market334
9.3.2 Stopcock Market by Flow Type335
9.3.2.1 One-Way Stopcock Market336
9.3.2.2 Two-Way Stopcock Market337
9.3.2.3 Three-Way Stopcock Market338
9.3.2.4 Four-Way Stopcock Market339
9.3.3 Stopcock Market by Care Setting340
9.3.3.1 Hospital Stopcock Market342
9.3.3.2 Specialty Clinics Stopcock Market343
9.3.3.3 Ambulatory Surgical Center Stopcock Market344
9.3.3.4 Home Care Setting Stopcock Market345
9.4 Drivers and Limiters346
9.4.1 Market Drivers346
9.4.2 Market Limiters346
9.5 Competitive Market Share Analysis348
Intravenous Filter Market352
10.1 Introduction352
10.2 Market Overview354
10.2.1 Market Overview by Care Setting354
10.3 Market Analysis and Forecast356
10.3.1 Total Intravenous Filter Market356
10.3.2 Intravenous Filter Market by Care Setting358
10.3.2.1 Hospital Intravenous Filter Market359
10.3.2.2 Specialty Clinics Intravenous Filter Market361
10.3.2.3 Ambulatory Surgical Center Intravenous Filter Market363
10.3.2.4 Home Care Setting Intravenous Filter Market365
10.4 Drivers and Limiters367
10.4.1 Market Drivers367
10.4.2 Market Limiters367
10.5 Competitive Market Share Analysis369
Blood Transfusion Device Market372
11.1 Introduction372
11.2 Market Overview373
11.2.1 Market Overview by Chamber Type373
11.2.2 Market Overview by Care Setting376
11.3 Market Analysis and Forecast378
11.3.1 Total Blood Transfusion Device Market378
11.3.2 Blood Transfusion Device Market by Chamber Type379
11.3.2.1 Single-Chamber Blood Transfusion Device Market380
11.3.2.2 Dual-Chamber Blood Transfusion Device Market381
11.3.3 Blood Transfusion Device Market by Care Setting382
11.3.3.1 Hospital Blood Transfusion Device Market383
11.3.3.2 Specialty Clinics Blood Transfusion Device Market385
11.3.3.3 Other Blood Transfusion Device Market387
11.4 Drivers and Limiters389
11.4.1 Market Drivers389
11.4.2 Market Limiters389
11.5 Competitive Market Share Analysis390
Abbreviations394
The Infusion Therapy Device Market Report Suite | United States | 2023-2029 | MedSuite includes analysis on the following companies currently active in this market:
·         3M·         IRadimed
·         Ace Medical·         ITW Filtertek
·         Actimed·         Ivenix
·         Ambu·         Medcaptain
·         Amsino·         Mediplast
·         Argon Medical Devices·         Mindray
·         Avanos Medical·         Moog
·         B. Braun·         Nexus Medical
·         Baxter·         Nipro Medical
·         Becton Dickinson·         Nordson Medical
·         Belmont Medical Technologies·         NP Medical
·         CODAN USA·         Pall Corporation
·         CoMedical·         Promed
·         Eitan Medical·         QinFlow
·         Elcam·         Qosina
·         Fresenius·         Rymed Technologies
·         FutureMed America·         Samtronic
·         GVS Group·         Smisson-Cartledge Biomedical
·         Halkey Roberts·         Vygon
·         Hospira·         Walkmed Infusion
·         ICU Medical·         Zyno Medical

List of Charts

List of Charts
Chart 1‑1: Infusion Therapy Device Market by Segment, U.S., 2022 – 20293
Chart 1‑2: Infusion Therapy Device Market Overview, U.S., 2022 & 20293
Chart 2‑1: Multi-Scenario Infusion Therapy Device Market Forecast, U.S., 2019 – 2029 (US$M)35
Chart 5‑1: Infusion Therapy Device Market by Segment, U.S., 2019 – 202991
Chart 5‑2: Leading Competitors, Infusion Therapy Device Market, U.S., 2022102
Chart 6‑1: Infusion Pump Market by Segment, U.S., 2019 – 2029131
Chart 6‑2: Leading Competitors, Infusion Pump Market, U.S., 2022200
Chart 7‑1: Intravenous Set Market by Device Type, U.S., 2019 – 2029204
Chart 7‑2: Intravenous Set Market by Material, U.S., 2019 – 2029206
Chart 7‑3: Leading Competitors, Intravenous Set Market, U.S., 2022288
Chart 8‑1: Needleless Connector Market by Valve Type, U.S., 2019 – 2029292
Chart 8‑2: Needleless Connector Market by Device Type, U.S., 2019 – 2029294
Chart 8‑3: Needleless Connector Market by Antimicrobial Coating, U.S., 2019 – 2029296
Chart 8‑4: Needleless Connector Market by Care Setting, U.S., 2019 – 2029298
Chart 8‑5: Leading Competitors, Needleless Connector Market, U.S., 2022327
Chart 9‑1: Stopcock Market by Segment, U.S., 2019 – 2029331
Chart 9‑2: Stopcock Market by Care Setting, U.S., 2019 – 2029333
Chart 9‑3: Leading Competitors, Stopcock Market, U.S., 2022351
Chart 10‑1: Intravenous Filter Market by Care Setting, U.S., 2019 – 2029355
Chart 10‑2: Leading Competitors, Intravenous Filter Market, U.S., 2022371
Chart 11‑1: Blood Transfusion Device Market by Chamber Type, U.S., 2019 – 2029375
Chart 11‑2: Blood Transfusion Device Market by Care Setting, U.S., 2019 – 2029377
Chart 11‑3: Leading Competitors, Blood Transfusion Device Market, U.S., 2022393

LIST OF FIGURES

List of Figures
Figure 1‑1: Infusion Therapy Device Market Share Ranking by Segment, U.S., 20225
Figure 1‑2: Companies Researched in This Report6
Figure 1‑3: Factors Impacting the Infusion Therapy Device Market by Segment, U.S.7
Figure 1‑4: Recent Events in the Infusion Therapy Device Market, U.S., 2019 – 20238
Figure 1‑5: Infusion Therapy Device Markets Covered (1 of 5)9
Figure 1‑6: Infusion Therapy Device Markets Covered (2 of 5)10
Figure 1‑7: Infusion Therapy Device Markets Covered (3 of 5)11
Figure 1‑8: Infusion Therapy Device Markets Covered (4 of 5)12
Figure 1‑9: Infusion Therapy Device Markets Covered (5 of 5)13
Figure 1‑10: Key Report Updates14
Figure 1‑11: Version History15
Figure 2‑1: Infusion Therapy Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M)32
Figure 2‑2: Infusion Therapy Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M)33
Figure 2‑3: Infusion Therapy Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M)34
Figure 4‑1: Large-Volume Infusion Pumps by Company51
Figure 4‑2: Intravenous Sets by Company (1 of 2)53
Figure 4‑3: Intravenous Sets by Company (2 of 2)54
Figure 4‑4: Needleless Connectors by Company57
Figure 4‑5: Stopcocks by Company59
Figure 4‑6: Intravenous Filters by Company60
Figure 4‑7: Blood Transfusion Sets by Company61
Figure 4‑8: Class 1 Device Recall Baxter Spectrum IQ62
Figure 4‑9: Class 1 Device Recall Baxter SIGMA Spectrum62
Figure 4‑10: Class 1 Device Recall Spectrum IQ Infusion System with Dose IQ Safety Software62
Figure 4‑11: Class 2 Device Recall Spectrum IQInfusion Pump63
Figure 4‑12: Class 2 Device Recall SIGMA Spectrum Infusion Pump63
Figure 4‑13: Class 1 Device Recall Spectrum IQ63
Figure 4‑14: Class 1 Device Recall Baxter SIGMA Spectrum Infusion Pump63
Figure 4‑15: Class 2 Device Recall Baxter SIGMA Spectrum Infusion Pump64
Figure 4‑16: Class 2 Device Recall B. Braun64
Figure 4‑17: Class 2 Device Recall Infusomat Space Volumetric Pump Administration Set64
Figure 4‑18: Class 1 Device Recall Infusomat Space Volumetric Infusion Pump Administration Set65
Figure 4‑19: Class 2 Device Recall Alaris PC Unit65
Figure 4‑20: Class 1 Device Recall Alaris Infusion Pump Module65
Figure 4‑21: Class 1 Device Recall Alaris Pump Module65
Figure 4‑22: Class 1 Device Recall Alaris Pump Module66
Figure 4‑23: Class 1 Device Recall Alaris Pump66
Figure 4‑24: Class 1 Device Recall BD Alaris Pump Module66
Figure 4‑25: Class 1 Device Recall BD Alaris System PC Unit67
Figure 4‑26: Class 1 Device Recall Alaris System PC Unit67
Figure 4‑27: Class 1 Device Recall Alaris Infusion Pump System67
Figure 4‑28: Class 2 Device Recall BD Alaris" System67
Figure 4‑29: Class 2 Device Recall Alaris Pump Module68
Figure 4‑30: Class 2 Device Recall Alaris Syringe Module68
Figure 4‑31: Class 2 Device Recall Alaris PCA Module68
Figure 4‑32: Class 1 Device Recall CareFusion Alaris Pump69
Figure 4‑33: Class 2 Device Recall Plum 360 Infusion System with MedNet/Smart Card Plug n Play Module69
Figure 4‑34: Class 1 Device Recall Medfusion Model 4000 Pump69
Figure 4‑35: Class 2 Device Recall Medfusion Model 4000 Syringe Infusion Pump70
Figure 4‑36: Class 2 Device Recall Clearlink System ContinuFlo Administration Sets71
Figure 4‑37: Class 2 Device Recall Infusomat Space Volumetric Pump Administration Set71
Figure 4‑38: Class 1 Device Recall Infusomat Space Volumetric Infusion Pump Administration Set71
Figure 4‑39: Class 2 Device Recall BD Extension Set SMALLBORE Tubing with 2 SmartSite VALVES72
Figure 4‑40: Class 2 Device Recall BD SmartSite 'Y' Extension Set 2 NeedleFree Valves72
Figure 4‑41: Class 2 Device Recall BD Extension Set SMALLBORE Tubing SmartSite VALVE72
Figure 4‑42: Class 2 Device Recall BD Gravity IV Set 3port Closed Manifold Back Check Valve 3 NeedleFree Ysites73
Figure 4‑43: Class 2 Device Recall MaxPlus Bi Fuse Extension Set with 2 Clear Needleless Connectors73
Figure 4‑44: Class 2 Device Recall BD Alaris PCEA Administration Set73
Figure 4‑45: Class 2 Device Recall MaxZero74
Figure 4‑46: Class 1 Device Recall SmartSite Syringe Administration Set74
Figure 4‑47: Class 2 Device Recall Plum 360 Infusion System74
Figure 4‑48: Class 2 Device Recall Sapphire Primary 1.2 Micron Filter Set Microbore Plum Microbore Infusion Sets with Inline Filter74
Figure 4‑49: Class 2 Device Recall ONELINK Needlefree IV Connector75
Figure 4‑50: Class 2 Device Recall MicroClave Clear Neutral Connector75
Figure 4‑51: Class 2 Device Recall BD SmartSite75
Figure 4‑52: Class 2 Device Recall ONELINK Needlefree IV Connector76
Figure 4‑53: Class 2 Device Recall Argon Medical Devices Stopcocks77
Figure 4‑54: Class 2 Device Recall BD Connecta Stopcocks77
Figure 4‑55: Class 2 Device Recall IV Administration Set78
Figure 4‑56: Class 2 Device Recall NAMIC Stopcocks78
Figure 4‑57: Class 2 Device Recall Infusion Stopcock78
Figure 4‑58: Class 2 Device Recall Medex stopcocks and manifolds78
Figure 4‑59: Class 1 Device Recall Fresh Whole Blood Transfusion Set79
Figure 4‑60: Class 1 Device Recall Low Titer Type O FWB Transfusion Set79
Figure 4‑61: Hepatic Artery Infusion Pump Chemotherapy with Floxuridine and Dexamethasone in Combination with Systemic Chemotherapy for Patients with Colorectal Cancer Metastatic to the Liver81
Figure 4‑62: Patient Outcomes After Hepatic Artery Infusion Pump Placement81
Figure 4‑63: Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin (EVOLVE)82
Figure 4‑64: ElastoMeric Infusion Pumps for Hospital AntibioTICs (EMPHATIC)82
Figure 4‑65: Prometra Post-Approval Study82
Figure 4‑66: Hepatic Arterial Infusion Pump Chemotherapy Combined with Systemic Chemotherapy (PUMP-IT)83
Figure 4‑67: Treatment of (IDA) by (FPC) Delivered via Infusion Pump in Patients Receiving Home Infusion Therapy83
Figure 4‑68: An Observational Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors84
Figure 4‑69: Blood Transfusion in Patients with Lung Cancer85
Figure 4‑70: Effect of Indication Based Blood Product Transfusion in Patients Undergoing Major Oncological Surgery85
Figure 5‑1: Infusion Therapy Device Market by Segment, U.S., 2019 – 2029 (US$M)90
Figure 5‑2: Leading Competitors, Infusion Therapy Device Market, U.S., 2022101
Figure 5‑3: SWOT Analysis, Avanos Medical117
Figure 5‑4: SWOT Analysis, B. Braun118
Figure 5‑5: SWOT Analysis, Baxter119
Figure 5‑6: SWOT Analysis, Becton Dickinson120
Figure 5‑7: SWOT Analysis, Belmont Medical121
Figure 5‑8: SWOT Analysis, CODAN122
Figure 5‑9: SWOT Analysis, Fresenius123
Figure 5‑10: SWOT Analysis, GVS Group124
Figure 5‑11: SWOT Analysis, ICU Medical125
Figure 5‑12: SWOT Analysis, Vygon126
Figure 6‑1: Infusion Pump Market by Segment, U.S., 2019 – 2029 (US$M)130
Figure 6‑2: Total Large-Volume Infusion Pump Market, U.S., 2019 – 2029133
Figure 6‑3: Large-Volume Infusion Pump Market by Care Setting, U.S., 2019 – 2029 (US$M)135
Figure 6‑4: Hospital Large-Volume Infusion Pump Market, U.S., 2019 – 2029137
Figure 6‑5: Specialty Clinics Care Large-Volume Infusion Pump Market, U.S., 2019 – 2029138
Figure 6‑6: Ambulatory Surgical Center Large-Volume Infusion Pump Market, U.S., 2019 – 2029139
Figure 6‑7: Home Care Setting Large-Volume Infusion Pump Market, U.S., 2019 – 2029140
Figure 6‑8: Large-Volume Infusion Pump Market by Modularity, U.S., 2019 – 2029 (US$M)142
Figure 6‑9: Modular Large-Volume Infusion Pump Market, U.S., 2019 – 2029143
Figure 6‑10: Non-Modular Large-Volume Infusion Pump Market, U.S., 2019 – 2029144
Figure 6‑11: Large-Volume Infusion Pump Market by MRI Compatibility, U.S., 2019 – 2029 (US$M)146
Figure 6‑12: MRI-Compatible Large-Volume Infusion Pump Market, U.S., 2019 – 2029147
Figure 6‑13: Non-MRI-Compatible Large-Volume Infusion Pump Market, U.S., 2019 – 2029148
Figure 6‑14: Total Syringe Infusion Pump Market, U.S., 2019 – 2029150
Figure 6‑15: Syringe Infusion Pump Market by Care Setting, U.S., 2019 – 2029 (US$M)152
Figure 6‑16: Hospital Syringe Infusion Pump Market, U.S., 2019 – 2029153
Figure 6‑17: Specialty Clinics Care Syringe Infusion Pump Market, U.S., 2019 – 2029154
Figure 6‑18: Ambulatory Surgical Center Syringe Infusion Pump Market, U.S., 2019 – 2029155
Figure 6‑19: Home Care Setting Syringe Infusion Pump Market, U.S., 2019 – 2029156
Figure 6‑20: Syringe Infusion Pump Market by Modularity, U.S., 2019 – 2029 (US$M)158
Figure 6‑21: Modular Syringe Infusion Pump Market, U.S., 2019 – 2029159
Figure 6‑22: Non-Modular Syringe Infusion Pump Market, U.S., 2019 – 2029160
Figure 6‑23: Total Patient-Controlled Analgesia Infusion Pump Market, U.S., 2019 – 2029162
Figure 6‑24: Patient-Controlled Analgesia Infusion Pump Market by Care Setting, U.S., 2019 – 2029 (US$M)164
Figure 6‑25: Hospital Patient-Controlled Analgesia Infusion Pump Market, U.S., 2019 – 2029165
Figure 6‑26: Specialty Clinics Patient-Controlled Analgesia Infusion Pump Market, U.S., 2019 – 2029166
Figure 6‑27: Ambulatory Surgical Center Patient-Controlled Analgesia Infusion Pump Market, U.S., 2019 – 2029167
Figure 6‑28: Home Care Setting Patient-Controlled Analgesia Infusion Pump Market, U.S., 2019 – 2029168
Figure 6‑29: Total Electronic Ambulatory Infusion Pump Market, U.S., 2019 – 2029169
Figure 6‑30: Electronic Ambulatory Infusion Pump Market by Care Setting, U.S., 2019 – 2029 (US$M)171
Figure 6‑31: Hospital Electronic Ambulatory Infusion Pump Market, U.S., 2019 – 2029172
Figure 6‑32: Specialty Clinics Electronic Ambulatory Infusion Pump Market, U.S., 2019 – 2029173
Figure 6‑33: Ambulatory Surgical Center Electronic Ambulatory Infusion Pump Market, U.S., 2019 – 2029174
Figure 6‑34: Home Care Setting Electronic Ambulatory Infusion Pump Market, U.S., 2019 – 2029175
Figure 6‑35: Total Disposable Ambulatory Infusion Pump Market, U.S., 2019 – 2029176
Figure 6‑36: Disposable Ambulatory Infusion Pump Market by Type, U.S., 2019 – 2029 (US$M)177
Figure 6‑37: Disposable Ambulatory Non-Pain Infusion Pump Market, U.S., 2019 – 2029178
Figure 6‑38: Disposable Ambulatory Pain Infusion Pump Market by Type, U.S., 2019 – 2029 (US$M)179
Figure 6‑39: Total Disposable Ambulatory Pain Infusion Pump Market, U.S., 2019 – 2029180
Figure 6‑40: Surgical Post-Operative Disposable Ambulatory Pain Infusion Pump Market, U.S., 2019 – 2029181
Figure 6‑41: Peripheral Nerve Block Disposable Ambulatory Pain Infusion Pump Market, U.S., 2019 – 2029182
Figure 6‑42: Disposable Ambulatory Infusion Pump Market by Care Setting, U.S., 2019 – 2029 (US$M)184
Figure 6‑43: Hospital Disposable Ambulatory Infusion Pump Market, U.S., 2019 – 2029185
Figure 6‑44: Specialty Clinics Disposable Ambulatory Infusion Pump Market, U.S., 2019 – 2029186
Figure 6‑45: Ambulatory Surgical Center Disposable Ambulatory Infusion Pump Market, U.S., 2019 – 2029187
Figure 6‑46: Home Care Setting Disposable Ambulatory Infusion Pump Market, U.S., 2019 – 2029188
Figure 6‑47: Leading Competitors, Infusion Pump Market, U.S., 2022199
Figure 7‑1: Intravenous Set Market by Device Type, U.S., 2019 – 2029 (US$M)203
Figure 7‑2: Intravenous Set Market by Material, U.S., 2019 – 2029 (US$M)205
Figure 7‑3: Total Pump Set Market, U.S., 2019 – 2029208
Figure 7‑4: Pump Set Market by Device Type, U.S., 2019 – 2029 (US$M)209
Figure 7‑5: Dedicated Pump Set Market by Application, U.S., 2019 – 2029 (US$M)211
Figure 7‑6: Total Dedicated Pump Set Market, U.S., 2019 – 2029211
Figure 7‑7: General Ward Dedicated Pump Set Market, U.S., 2019 – 2029212
Figure 7‑8: Burette Dedicated Pump Set Market, U.S., 2019 – 2029213
Figure 7‑9: Oncology Dedicated Pump Set Market, U.S., 2019 – 2029214
Figure 7‑10: Total Parenteral Nutrition Dedicated Pump Set Market, U.S., 2019 – 2029215
Figure 7‑11: Non-Dedicated Pump Set Market, U.S., 2019 – 2029216
Figure 7‑12: Pump Set Market by Light Protection, U.S., 2019 – 2029 (US$M)217
Figure 7‑13: Light-Protected Pump Set Market, U.S., 2019 – 2029218
Figure 7‑14: Non-Light-Protected Pump Set Market, U.S., 2019 – 2029219
Figure 7‑15: Pump Set Market by Patient Age, U.S., 2019 – 2029 (US$M)220
Figure 7‑16: Pediatric and Neonatal Pump Set Market, U.S., 2019 – 2029221
Figure 7‑17: Adult Pump Set Market, U.S., 2019 – 2029222
Figure 7‑18: Pump Set Market by Care Setting, U.S., 2019 – 2029 (US$M)223
Figure 7‑19: Hospital Pump Set Market, U.S., 2019 – 2029224
Figure 7‑20: Specialty Clinics Pump Set Market, U.S., 2019 – 2029225
Figure 7‑21: Ambulatory Surgical Center Pump Set Market, U.S., 2019 – 2029226
Figure 7‑22: Home Care Setting Pump Set Market, U.S., 2019 – 2029227
Figure 7‑23: Total Gravity Set Market, U.S., 2019 – 2029228
Figure 7‑24: Gravity Set Market by Application, U.S., 2019 – 2029 (US$M)229
Figure 7‑25: General Ward Gravity Set Market, U.S., 2019 – 2029230
Figure 7‑26: General Ward Set Market by Y-Site, U.S., 2019 – 2029 (US$M)231
Figure 7‑27: General Ward Gravity Set Market by Needle-Free Access Port, U.S., 2019 – 2029 (US$M)232
Figure 7‑28: General Ward Gravity Set with Y-Site Market, U.S., 2019 – 2029233
Figure 7‑29: General Ward Gravity Set with Y-Site with Needle-Free Access Port Market, U.S., 2019 – 2029234
Figure 7‑30: General Ward Gravity Set with Y-Site without Needle-Free Access Port Market, U.S., 2019 – 2029235
Figure 7‑31: General Ward Gravity Set without Y-Site Market, U.S., 2019 – 2029236
Figure 7‑32: General Ward Gravity Set Market by Filter, U.S., 2019 – 2029 (US$M)237
Figure 7‑33: General Ward Gravity Set with Filter Market, U.S., 2019 – 2029238
Figure 7‑34: General Ward Gravity Set without Filter Market, U.S., 2019 – 2029239
Figure 7‑35: General Ward Gravity Set Market by Stopcock, U.S., 2019 – 2029 (US$M)240
Figure 7‑36: General Ward Gravity Set with Stopcock Market, U.S., 2019 – 2029241
Figure 7‑37: General Ward Gravity Set without Stopcock Market, U.S., 2019 – 2029242
Figure 7‑38: General Ward Gravity Set Market by Flow Control, U.S., 2019 – 2029 (US$M)243
Figure 7‑39: General Ward Gravity Set with Flow Control Market, U.S., 2019 – 2029244
Figure 7‑40: General Ward Gravity Set without Flow Control Market, U.S., 2019 – 2029245
Figure 7‑41: Burette Gravity Set Market, U.S., 2019 – 2029246
Figure 7‑42: Oncology Gravity Set Market, U.S., 2019 – 2029247
Figure 7‑43: Gravity Set Market by Care Setting, U.S., 2019 – 2029 (US$M)248
Figure 7‑44: Hospital Gravity Set Market, U.S., 2019 – 2029249
Figure 7‑45: Specialty Clinics Gravity Set Market, U.S., 2019 – 2029250
Figure 7‑46: Ambulatory Surgical Center Gravity Set Market, U.S., 2019 – 2029251
Figure 7‑47: Home Care Setting Gravity Set Market, U.S., 2019 – 2029252
Figure 7‑48: Total Secondary Set Market, U.S., 2019 – 2029253
Figure 7‑49: Secondary Set Market by Care Setting, U.S., 2019 – 2029254
Figure 7‑50: Hospital Secondary Set Market, U.S., 2019 – 2029255
Figure 7‑51: Specialty Clinics Secondary Set Market, U.S., 2019 – 2029256
Figure 7‑52: Ambulatory Surgical Center Secondary Set Market, U.S., 2019 – 2029257
Figure 7‑53: Home Care Setting Secondary Set Market, U.S., 2019 – 2029258
Figure 7‑54: Total Extension Set Market, U.S., 2019 – 2029260
Figure 7‑55: Extension Set Market by Configuration, U.S., 2019 – 2029 (US$M)261
Figure 7‑56: Standard Extension Set Market, U.S., 2019 – 2029262
Figure 7‑57: Multi-Way Extension Set Market, U.S., 2019 – 2029263
Figure 7‑58: Extension Set Market by IV Filter, U.S., 2019 – 2029 (US$M)265
Figure 7‑59: Extension Set with Built-in IV Filter Market, U.S., 2019 – 2029266
Figure 7‑60: Extension Set without Built-in IV Filter Market, U.S., 2019 – 2029267
Figure 7‑61: Extension Set Market by Stopcock, U.S., 2019 – 2029 (US$M)268
Figure 7‑62: Extension Set with Built-in Stopcock Market, U.S., 2019 – 2029269
Figure 7‑63: Extension Set without Built-in Stopcock Market, U.S., 2019 – 2029270
Figure 7‑64: Extension Set Market by Flow Control, U.S., 2019 – 2029 (US$M)272
Figure 7‑65: Extension Set with Flow Control Market, U.S., 2019 – 2029273
Figure 7‑66: Extension Set without Flow Control Market, U.S., 2019 – 2029274
Figure 7‑67: Extension Set Market by Care Setting, U.S., 2019 – 2029 (US$M)275
Figure 7‑68: Hospital Extension Set Market, U.S., 2019 – 2029276
Figure 7‑69: Specialty Clinics Extension Set Market, U.S., 2019 – 2029277
Figure 7‑70: Ambulatory Surgical Center Extension Set Market, U.S., 2019 – 2029278
Figure 7‑71: Home Care Setting Extension Set Market, U.S., 2019 – 2029279
Figure 7‑72: DEHP IV Set Market, U.S., 2019 – 2029280
Figure 7‑73: Non-DEHP IV Set Market, U.S., 2019 – 2029281
Figure 7‑74: Leading Competitors, Intravenous Set Market, U.S., 2022287
Figure 8‑1: Needleless Connector Market by Valve Type, U.S., 2019 – 2029 (US$M)291
Figure 8‑2: Needleless Connector Market by Device Type, U.S., 2019 – 2029 (US$M)293
Figure 8‑3: Needleless Connector Market by Antimicrobial Coating, U.S., 2019 – 2029 (US$M)295
Figure 8‑4: Needleless Connector Market by Care Setting, U.S., 2019 – 2029 (US$M)297
Figure 8‑5: Total Needleless Connector Market, U.S., 2019 – 2029299
Figure 8‑6: Split Septum & Blunt Cannula Needleless Connector Market, U.S., 2019 – 2029301
Figure 8‑7: Mechanical Valve Needleless Connector Market by Device Type, U.S., 2019 – 2029 (US$M)303
Figure 8‑8: Total Mechanical Valve Needleless Connector Market, U.S., 2019 – 2029304
Figure 8‑9: Negative Displacement Mechanical Valve Needleless Connector Market, U.S., 2019 – 2029305
Figure 8‑10: Positive Displacement Mechanical Valve Needleless Connector Market, U.S., 2019 – 2029306
Figure 8‑11: Neutral Displacement Mechanical Valve Needleless Connector Market, U.S., 2019 – 2029307
Figure 8‑12: Anti-Reflux Neutral Displacement Mechanical Valve Needleless Connector Market, U.S., 2019 – 2029308
Figure 8‑13: Standalone Needleless Connector Market, U.S., 2019 – 2029310
Figure 8‑14: Integrated Needleless Connector Market, U.S., 2019 – 2029311
Figure 8‑15: Needleless Connector Market by Antimicrobial Coating, U.S., 2019 – 2029 (US$M)313
Figure 8‑16: Antimicrobial Needleless Connector Market, U.S., 2019 – 2029314
Figure 8‑17: Conventional Needleless Connector Market, U.S., 2019 – 2029315
Figure 8‑18: Needleless Connector Market by Care Setting, U.S., 2019 – 2029 (US$M)316
Figure 8‑19: Hospital Needleless Connector Market, U.S., 2019 – 2029317
Figure 8‑20: Specialty Clinics Needleless Connector Market, U.S., 2019 – 2029318
Figure 8‑21: Ambulatory Surgical Center Needleless Connector Market, U.S., 2019 – 2029320
Figure 8‑22: Home Care Setting Needleless Connector Market, U.S., 2019 – 2029321
Figure 8‑23: Leading Competitors, Needleless Connector Market, U.S., 2022326
Figure 9‑1: Stopcock Market by Flow Type, U.S., 2019 – 2029 (US$M)330
Figure 9‑2: Stopcock Market by Care Setting, U.S., 2019 – 2029 (US$M)332
Figure 9‑3: Total Stopcock Market, U.S., 2019 – 2029334
Figure 9‑4: One-Way Stopcock Market, U.S., 2019 – 2029336
Figure 9‑5: Two-Way Stopcock Market, U.S., 2019 – 2029337
Figure 9‑6: Three-Way Stopcock Market, U.S., 2019 – 2029338
Figure 9‑7: Four-Way Stopcock Market, U.S., 2019 – 2029339
Figure 9‑8: Stopcock Market by Care Setting, U.S., 2019 – 2029 (US$M)341
Figure 9‑9: Hospital Stopcock Market, U.S., 2019 – 2029342
Figure 9‑10: Specialty Clinics Stopcock Market, U.S., 2019 – 2029343
Figure 9‑11: Ambulatory Surgical Center Stopcock Market, U.S., 2019 – 2029344
Figure 9‑12: Home Care Setting Stopcock Market, U.S., 2019 – 2029345
Figure 9‑13: Leading Competitors, Stopcock Market, U.S., 2022350
Figure 10‑1: Intravenous Filter Market by Care Setting, U.S., 2019 – 2029 (US$M)354
Figure 10‑2: Total Intravenous Filter Market, U.S., 2019 – 2029357
Figure 10‑3: Hospital Intravenous Filter Market, U.S., 2019 – 2029360
Figure 10‑4: Specialty Clinics Intravenous Filter Market, U.S., 2019 – 2029362
Figure 10‑5: Ambulatory Surgical Center Intravenous Filter Market, U.S., 2019 – 2029364
Figure 10‑6: Home Care Setting Intravenous Filter Market, U.S., 2019 – 2029366
Figure 10‑7: Leading Competitors, Intravenous Filter Market, U.S., 2022370
Figure 11‑1: Blood Transfusion Device Market by Chamber Type, U.S., 2019 – 2029 (US$M)374
Figure 11‑2: Blood Transfusion Device Market by Care Setting, U.S., 2019 – 2029 (US$M)376
Figure 11‑3: Total Blood Transfusion Device Market, U.S., 2019 – 2029378
Figure 11‑4: Single-Chamber Blood Transfusion Device Market, U.S., 2019 – 2029380
Figure 11‑5: Dual-Chamber Blood Transfusion Device Market, U.S., 2019 – 2029381
Figure 11‑6: Hospital Blood Transfusion Device Market, U.S., 2019 – 2029384
Figure 11‑7: Specialty Clinics Blood Transfusion Device Market, U.S., 2019 – 2029386
Figure 11‑8 Other Blood Transfusion Device Market, U.S., 2019 – 2029388
Figure 11‑9: Leading Competitors, Blood Transfusion Device Market, U.S., 2022392

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

  • 2023
  • 10 Years
  • United States
  • 05/04/23
  • 395
  • MedSuite
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library